WPWashington Post·2dHealth
score-0.40
Lawsuits prompt debate over warning standards for rare risks in widely used GLP-1 drugs
Original
The GLP-1 boom has a dark side — even if serious complications are rare
“Uses 'dark side' and 'devastating risk' to create caution without alarmism, balanced by acknowledging rarity.”